NatWest


EPS upgrades on faster cost of risk normalisation

22/02/21 -"As announced in our post-release comments, we have upgraded our forecasts for 2021. This was fully driven by the sharply reduced loan impairments projections (down £1.4bn to £1.1bn), whereas we have ..."

Pages
61
Language
English
Published on
22/02/21
You may also be interested by these reports :
02/02/26
Operational resilience amid the clean-up phase, Julius Baer’s second half 2025 results outperformed consensus expectations. While earnings were ...

02/02/26
The fourth-quarter results were largely in line with guidance, thus enabling the management to confirm its 2026 net profit objective. The cautious ...

02/02/26
SEB’s Q4 PBT missed consensus by 10%, pressured by NII compression and negative jaws. While FY RoE (13.8%) lagged targets, a robust 17.7% CET1 ratio ...

30/01/26
Nordea delivered strong Q4 2025 results with a 15.5% FY RoE, exceeding guidance. Total income remained flat as higher trading and fee results offset ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO